Initially synthesized in the late 1950s, Drostanolone Enanthate is a synthetic anabolic steroid derived from dihydrotestosterone. Designed for medical applications such as treating muscle wasting and breast cancer, the enanthate ester was developed to prolong its effects, enabling less frequent dosing. Appeal in the bodybuilding community lies in its ability to increase muscle density and strength without causing water retention. However categorizing the substance as controlled raises concerns, about its misuse in sports and potential health hazards leading to a discussion, about its benefits and performance enhancing properties.
Choudhary, M. I., Siddiqui, M., Yousuf, S., (2017). Bio-catalytic structural transformation of anti-cancer steroid, drostanolone enanthate with Cephalosporium aphidicola and Fusarium lini, and cytotoxic potential evaluation of its metabolites against certain cancer cell lines. Frontiers in Pharmacology.
Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.
For detailed information about PHARMADRO E 200 by Pharmacom Labs, consult with your doctor or healthcare professional.
Choudhary, M. I., Siddiqui, M., Yousuf, S., (2017). Bio-catalytic structural transformation of anti-cancer steroid, drostanolone enanthate with Cephalosporium aphidicola and Fusarium lini, and cytotoxic potential evaluation of its metabolites against certain cancer cell lines. Frontiers in Pharmacology.
Choudhary, M. I., Siddiqui, M., Yousuf, S., (2017). Bio-catalytic structural transformation of anti-cancer steroid, drostanolone enanthate with Cephalosporium aphidicola and Fusarium lini, and cytotoxic potential evaluation of its metabolites against certain cancer cell lines. Frontiers in Pharmacology.
Choudhary, M. I., Siddiqui, M., Yousuf, S., (2017). Bio-catalytic structural transformation of anti-cancer steroid, drostanolone enanthate with Cephalosporium aphidicola and Fusarium lini, and cytotoxic potential evaluation of its metabolites against certain cancer cell lines. Frontiers in Pharmacology.